Literature DB >> 29529219

Effect of the Procalcitonin Assay on Antibiotic Use in Critically Ill Children.

Rachael K Ross1, Luke Keele2, Sherri Kubis3, Andrew J Lautz4, Adam C Dziorny5, Adam R Denson5, Kathleen A O'Connor5, Marianne R Chilutti6, Scott L Weiss5, Jeffrey S Gerber1,7.   

Abstract

We retrospectively studied the effect of introducing procalcitonin into clinical practice on antibiotic use within a large academic pediatric intensive care unit. In the absence of a standardized algorithm, availability of the procalcitonin assay did not reduce the frequency of antibiotic initiations or the continuation of antibiotics for greater than 72 hours.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29529219     DOI： 10.1093/jpids/piy004

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


  3 in total

1.  Implementation of a Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) II Study.

Authors:  Kevin J Downes; Julie C Fitzgerald; Emily Schriver; Craig L K Boge; Michael E Russo; Scott L Weiss; Fran Balamuth; Sherri E Kubis; Pam Tolomeo; Warren B Bilker; Jennifer H Han; Ebbing Lautenbach; Susan E Coffin; Jeffrey S Gerber
Journal:  J Pediatric Infect Dis Soc       Date:  2020-02-28       Impact factor: 3.164

2.  Use of a Procalcitonin-guided Antibiotic Treatment Algorithm in the Pediatric Intensive Care Unit.

Authors:  Sophie E Katz; Jennifer Crook; Jessica Gillon; J Eric Stanford; Li Wang; Jennifer M Colby; Ritu Banerjee
Journal:  Pediatr Infect Dis J       Date:  2021-04-01       Impact factor: 3.806

Review 3.  Future Biomarkers for Infection and Inflammation in Febrile Children.

Authors:  Judith Zandstra; Ilse Jongerius; Taco W Kuijpers
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.